Načítá se...
Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
BACKGROUND: Inhibition of angiogenesis using monoclonal antibodies is an effective strategy in cancer therapy. However, they could not penetrate sufficiently into solid tumors. Antibody fragments have solved this issue. However, they suffer from short in vivo half-life. In the current study, a tande...
Uloženo v:
| Vydáno v: | Avicenna J Med Biotechnol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Avicenna Research Institute
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8112138/ https://ncbi.nlm.nih.gov/pubmed/34012520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/ajmb.v13i2.5519 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|